Literature DB >> 1736326

Results of postoperative radiation therapy in medullary carcinoma of the thyroid: a retrospective study by the French Federation of Cancer Institutes--the Radiotherapy Cooperative Group.

T D Nguyen1, J L Chassard, P Lagarde, B Cutuli, R Le Fur, M Reme-Saumon, B Prevost, X Panis, P Verrelle, G Chaplain.   

Abstract

Between 1971 and 1989, 59 patients received external radiation therapy with a curative intent. There were 25 females and 34 males, ranging in age from 19 to 87. No patients had distant metastasis at the onset of treatment. The majority of patients had a total thyroidectomy (55/59), generally combined with neck dissection. Residual tumour was left in 11 cases, and 44 patients had positive cervical nodes. Using megavoltage radiotherapy, the whole neck and the upper mediastinum area were most often irradiated through a large anterior Y-shaped field without laryngeal shielding. The mean dose to the tumoral bed was 54 Gy. Dysphagia was observed in 32 patients (11, 17 and 5 scores were grade 1, 2 and 3, respectively). Dyspnea occurred in five cases and in two of these cases, it was considered to be severe. Local recurrences were noted in 18 (30%) patients, most of them occurring within the fields of irradiation. Parameters such as age, sex, total dose, irradiated volumes or cervical node enlargement did not modify the local control rate. The same conclusions can be drawn for distant failures. Thirty five patients are still alive and among them, 24 have no evidence of disease. The average length of survival is 70.5 months and is shortened by the occurrence of distant failures except in patients with bone metastases.

Entities:  

Mesh:

Year:  1992        PMID: 1736326     DOI: 10.1016/0167-8140(92)90298-9

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

1.  Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma.

Authors:  P Gasparoni; D Rubello; G Ferlin
Journal:  J Endocrinol Invest       Date:  1997-10       Impact factor: 4.256

Review 2.  Drug therapy alternatives in the treatment of thyroid cancer.

Authors:  M J O'Doherty; A J Coakley
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 3.  Medullary thyroid cancer.

Authors:  E Kebebew; O H Clark
Journal:  Curr Treat Options Oncol       Date:  2000-10

Review 4.  Medullary thyroid cancer: medical management and follow-up.

Authors:  Amber Traugott; Jeffrey F Moley
Journal:  Curr Treat Options Oncol       Date:  2005-07

5.  Fine needle aspiration cytology as the primary diagnostic tool in thyroid enlargement.

Authors:  Arup Sengupta; Ranabir Pal; Sumit Kar; Forhad Akhtar Zaman; Subhabrata Sengupta; Shrayan Pal
Journal:  J Nat Sci Biol Med       Date:  2011-01

6.  Recurrent spinal metastasis of a sporadic medullary carcinoma of the thyroid after radiation therapy: a case report and review of the literature.

Authors:  Christopher Munoz-Bendix; Antonio Santacroce; Kristin Gierga; Frank W Floeth; Hans-Jakob Steiger; Marco Antonio Penalonzo; Sven Oliver Eicker
Journal:  Clin Case Rep       Date:  2015-11-09

7.  Neutron radiation therapy for advanced thyroid cancers.

Authors:  Tobias R Chapman; George E Laramore; Stephen R Bowen; Peter F Orio
Journal:  Adv Radiat Oncol       Date:  2016-05-25

Review 8.  Multiple endocrine neoplasia type 2.

Authors:  Michael E Gertner; Electron Kebebew
Journal:  Curr Treat Options Oncol       Date:  2004-08

9.  Medullary thyroid carcinoma.

Authors:  Jeffrey F Moley
Journal:  Curr Treat Options Oncol       Date:  2003-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.